India Drug Patents
Drug Patents in India and US Equivalents
| Patent Number | Estimated Expiration | Equivalent US Patent | US Expiry Date | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|---|---|
| 3377DEN2012 | ⤷ Start Trial | 10772888 | 2032-03-30 | raltegravir potassium | Msd Sub Merck | ISENTRESS |
| 3377DEN2012 | ⤷ Start Trial | 10772888 | 2032-03-30 | raltegravir potassium | Msd Sub Merck | ISENTRESS HD |
| 42DEN2015 | ⤷ Start Trial | 11139056 | 2033-06-05 | bupropion hydrochloride; naltrexone hydrochloride | Nalpropion | CONTRAVE |
| 42DEN2015 | ⤷ Start Trial | 10403170 | 2033-06-05 | bupropion hydrochloride; naltrexone hydrochloride | Nalpropion | CONTRAVE |
| 449KON2015 | ⤷ Start Trial | 10869869 | 2034-02-28 | dabrafenib mesylate | Novartis | TAFINLAR |
| 449KON2015 | ⤷ Start Trial | 10869869 | 2034-02-28 | trametinib dimethyl sulfoxide | Novartis | MEKINIST |
| 6125DEN2014 | ⤷ Start Trial | 10117844 | 2033-01-04 | omega-3-carboxylic acids | Astrazeneca | EPANOVA |
| >Patent Number | >Estimated Expiration | >Equivalent US Patent | >US Expiry Date | >Generic Name | >US Applicant | >US Tradename |
